James Finn

James serves as the Senior Director of Lab Operations at SEED and has 28 years of experience in drug discovery with a B.S. in Biology from West Chester University. James’ strong leadership and communication skills are critical to SEED’s research workflow and preclinical research development efforts, where he manages both internal departments and external agencies.
Prior to SEED, James led target engagement studies in oncology and neurodegenerative diseases for Cephalon’s small molecule pipeline. His work in CNS drug discovery includes novel primary culture screening, which led to three INDs and the approval of Modafinil. James has also driven target validation and proof-of-concept studies in Parkinson’s and Alzheimer’s models, developed cell-based assays for oncology targets, and identified mechanisms of action and biomarkers supporting two IND-enabling studies.